Drugs / Live, attenuated measles vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00463684 | Jul → Nov 2007 | Japanese encephalitis | PATH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live, attenuated measles vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00463684 ↗ |
| Modality | Vaccine | “live, attenuated measles vaccine” NCT00463684 ↗ |
| Route | Subcutaneous | “Administered subcutaneously in the left brachium.” NCT00463684 ↗ |